Innospec Schedules Fourth Quarter 2022 Earnings Release and Conference Call
10 Gennaio 2023 - 10:45PM
Innospec Inc. (NASDAQ: IOSP) today announced that it will release
fourth quarter 2022 earnings results on Tuesday, February 21, 2023
after market close. Following the release of its results, Patrick
S. Williams, President and Chief Executive Officer, and Ian
Cleminson, Executive Vice President and Chief Financial Officer,
will host an interactive conference call on Wednesday, February 22,
2023, at 9:00 a.m. ET.
The public is invited to listen to the
conference call by registering in advance using the below Online
Registration Link. Upon registering, each participant will
receive an email confirmation with dial-in numbers and a unique
Personal PIN which can be used to join the conference 5-10 minutes
prior to the start time.
Online Registration Link:
https://register.vevent.com/register/BI1cc87a3a58604b57a97e838d79d7aa39
An audio webcast of the conference call will run
simultaneously on the company’s website at www.innospec.com. The
relevant link as well as the slide presentation for the conference
call will be found in the Investor Relations section of the
website.
A replay of the webcast can also be accessed
from the company’s website and will be available for 30 days
following the call.
About Innospec Inc.
Innospec Inc. is an international specialty
chemicals company with approximately 1,900 employees in 24
countries. Innospec manufactures and supplies a wide range of
specialty chemicals to markets in the Americas, Europe, the Middle
East, Africa and Asia-Pacific. The Performance Chemicals
business creates innovative technology-based solutions for our
customers in the Personal Care, Home Care, Agrochemical, Mining and
Industrial markets. The Fuel Specialties business specializes in
manufacturing and supplying fuel additives that improve fuel
efficiency, boost engine performance and reduce harmful emissions.
Oilfield Services provides specialty chemicals to all elements of
the oil and gas exploration and production industry.
Forward-Looking Statements
This press release contains certain
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. All statements
other than statements of historical facts included or incorporated
herein may constitute forward-looking statements. Such
forward-looking statements include statements (covered by words
like “expects,” “estimates,” “anticipates,” “may,” “could,”
“believes,” “feels,” “plans,” “intends” or similar words or
expressions, for example) which relate to earnings, growth
potential, operating performance, events or developments that we
expect or anticipate will or may occur in the future.
Although forward-looking statements are believed by management to
be reasonable when made, they are subject to certain risks,
uncertainties and assumptions, including, the effects of the
COVID-19 pandemic, such as its duration, its unknown long-term
economic impact, measures taken by governmental authorities to
address it, the rise of variants, the effectiveness, acceptance and
distributions of COVID-19 vaccines and the effects of any
sanctions, export restrictions, inflation, supply chain disruptions
or increased economic uncertainty related to the ongoing conflict
between Russia and Ukraine and the manner in which the pandemic
and/or such conflict may precipitate or exacerbate other risks
and/or uncertainties, and our actual performance or results may
differ materially from these forward-looking statements.
Additional information regarding risks, uncertainties and
assumptions relating to Innospec and affecting our business
operations and prospects are described in Innospec’s Annual Report
on Form 10-K for the year ended December 31, 2021, Innospec’s
Quarterly Report on Form 10-Q for the quarter ended September 30,
2022 and other reports filed with the U.S. Securities and Exchange
Commission. You are urged to review our discussion of risks
and uncertainties that could cause actual results to differ from
forward-looking statements under the heading "Risk Factors” in such
reports. Innospec undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
Contacts:Corbin BarnesInnospec
Inc.+44-151-355-3611Corbin.Barnes@innospecinc.com
Grafico Azioni Innospec (NASDAQ:IOSP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Innospec (NASDAQ:IOSP)
Storico
Da Giu 2023 a Giu 2024